Lab Information
Christian Pineau (MD)
InvestigatorClinical Research Unit
Department of Medicine (McGill)
Research Profile
Keywords
Lupus • morbidity • cardiovascular disease • vasculitis • adherence to treatment • prognostic factorsResearch Interests
My research focuses on defining and limiting the burden of cardiovascular disease and non-vascular cardiac diseases in SLE. Aside from conducting research to delineate the extent to which SLE patients suffer from sequelae of the disease (both related to cardiac and other morbidities), I have actively pursued strategies aimed at preventing cardiac disease in the systemic lupus patients that are served by the Montreal General Hospital Lupus Clinic. This has included focusing more attention on potentially reversible risk factors for cardiac disease, such as hypertension, cholesterol, antiphospholipid antibodies, and homocysteine. To the practice of annual assessments of SLE patients for general health issues, I have advocated for and successfully introduced the yearly systematic evaluation of some of these particular cardiac risk factors.Team Members
| Name | Position |
|---|
Latest Publications
- Sacre, K., Vinet, E., Pineau, C. A., Mendel, A., Kalache, F., Grenier, L.-P., Huynh, T. & Bernatsky, S. (2024). N-Terminal pro-Brain Natriuretic Peptide is a biomarker for cardiovascular damage in systemic lupus erythematous: a cross-sectional study. Rheumatology (Oxford, England), vol. 63, p. 1739-1745.
- Ouchene, L., Muntyanu, A., Assayag, D., Veilleux, È., Abril, A., Ferrara, G., Yacyshyn, E., Pineau, C. A., O'Brien, E., Baron, M., Osman, M., Gniadecki, R. & Netchiporouk, E. (2023). Skin disorders and interstitial lung disease: Part II-The spectrum of cutaneous diseases with lung disease association. Journal of the American Academy of Dermatology, vol. 88, p. 767-782.
- Desmarais, J., Fett, N., Rosenbaum, J. T., Costenbader, K. H., Ginzler, E. M., Goodman, S., O'Dell, J., Pineau, C. A., Schmajuk, G., Werth, V. P., Link, M. S. & Kovacs, R. (2022). Reply. Arthritis & rheumatology (Hoboken, N.J.), vol. 74, p. 1301.
- Barbacki, A., Rached-d'Astous, N., Pineau, C. A., Vinet, E., Grenier, L.-P., Kalache, F., Fallavollita, S., Lukusa, L. & Bernatsky, S. (2022). Clinical Significance of Raynaud Phenomenon in Systemic Lupus Erythematosus. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, vol. 28, p. e488-e490.
- Zhao, N., Al-Aly, Z., Zheng, B., van Donkelaar, A., Martin, R. V., Pineau, C. A. & Bernatsky, S. (2022). Fine particulate matter components and interstitial lung disease in rheumatoid arthritis. The European respiratory journal, vol. 60.
- Liu, J. L., Pineau, C. A., Grenier, L.-P., Vinet, E., Kalache, F., Lukusa, L. & Bernatsky, S. (2021). Treatment patterns and control of hypertension in systemic lupus erythematosus (SLE): a cross-sectional study. BMJ open, vol. 11, p. e048384.
- Desmarais, J., Rosenbaum, J. T., Costenbader, K. H., Ginzler, E. M., Fett, N., Goodman, S., O'Dell, J., Pineau, C. A., Schmajuk, G., Werth, V. P., Link, M. S. & Kovacs, R. (2021). American College of Rheumatology White Paper on Antimalarial Cardiac Toxicity. Arthritis & rheumatology (Hoboken, N.J.), vol. 73, p. 2151-2160.
- Zheng, B., Soares de Moura, C., Machado, M., Pineau, C. A., Curtis, J. R., Vinet, E. & Bernatsky, S. (2022). Association between chronic obstructive pulmonary disease, smoking, and interstitial lung disease onset in rheumatoid arthritis. Clinical and experimental rheumatology, vol. 40, p. 1280-1284.
- Lambert-Fliszar, F., Bernatsky, S., Kalache, F., Grenier, L.-P., Pineau, C. A. & Vinet, E. (2021). Personalised therapy during preconception and gestation in SLE: usefulness of 6-mercaptopurine metabolite levelswith azathioprine. Lupus science & medicine, vol. 8.
- Cotton, T., Niaki, O. Z., Zheng, B., Pineau, C. A., Fritzler, M., Vinet, E., Clarke, A. E. & Bernatsky, S. (2021). Myositis in systemic lupus erythematosus. Lupus, vol. 30, p. 615-619.
See also
